[ARWR] YoY Quarter Result on 30-Sep-2009 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
22-Dec-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q4]
Profit Trend
QoQ- -36.81%
YoY- 60.04%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 44 290,848 181 203 -60 578 39 2.02%
PBT -5,601 -2,947 -6,957,038 -19,308,392 -27,089,030 -18,997,209 -18,997,209 -74.16%
Tax -22,110,563 -14,078,360 -3,770 -15,848 -18,431 -22,359 -10,218 259.22%
NP -5,314 -2,777 -2,004 -3,460 -8,658 -7,573 -8,780 -8.02%
Tax Rate - - - - - - - -
Total Cost 5,357 293,624 2,185 3,663 8,598 8,151 8,819 -7.96%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin -12,145.56 -0.95 -1,109.12 -1,707.96 14,479.21 -1,310.07 -22,380.19 -9.67%
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
EPS -0.38 -0.27 -0.28 -0.59 -2.02 -1.96 -2.58 -27.30%
EPS Diluted -0.38 -0.27 -0.28 -0.59 -2.02 -1.96 -2.57 -27.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.